Humacyte (HUMA) Earnings Date & Reports

Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

HUMA is expected to report earnings to fall 42.50% to -9 cents per share on November 06

Q3'26

Est.

$-0.09

Q2'26

Missed

by $0.07

Q1'26

Beat

by $0.03

Q4'25

Est.

$-0.13

Q3'25

Beat

by $0.05

The last earnings report on August 12 showed earnings per share of -15 cents, missing the estimate of -9 cents. With 3.37M shares outstanding, the current market capitalization sits at 152.01M.

View a ticker or compare two or three

HUMA

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for HUMA